Clinical outcomes of heart transplantation using hepatitis c-viremic donors: A systematic review with meta-analysis

• Published in: The Journal of heart and lung transplantation Vol. 41; no. 4; pp. 538 - 549
• Main Authors: Villegas-Galaviz, Josue, Anderson, Eve, Guglin, Maya
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.04.2022
• Subjects: Antiviral Agents - therapeutic use; cardiac transplantation; direct-acting antivirals; Heart Transplantation; Hepacivirus; Hepatitis C - drug therapy; hepatitis c non-viremic recipients; hepatitis c viremic donors; hepatitis c virus; Hepatitis C, Chronic - drug therapy; Humans; nucleic acid amplification test; Tissue Donors; hepatitis c viremic donors; NAT; heart transplantation; hepatitis c non-viremic recipients; DAA; cardiac transplantation; SVR12; HTx; ISHLT; NAT+Ds; direct-acting antivirals; ACR; hepatitis c virus; NAT-Rs; HCV; IPD; nucleic acid amplification test

Heart transplantation (HTx) from hepatitis C virus (HCV)-viremic donors to nonviremic recipients decreases mortality and costs. Consequently, many transplant centers have reported their results using this strategy. Hence, there is a need for an outcome analysis. We performed a systematic review with...